Clinical trial teams need to understand that not all solutions are “one size fits all” and how to implement a “fit for purpose” model for each study, expert says.
“We can provide patients who have traditionally been left out of the clinical trial process with an opportunity to participate or learn more.”
Patients aren’t joining clinical trials for the small reimbursements they may receive, expert says. “They know their volunteerism can advance science and help others.”
“If our objective [as an industry] is to develop trials with populations that reflect the real world, we must include everyone—it’s a moral and scientific imperative.”
With the COVID-19 pandemic far from being conquered across much of the globe but becoming somewhat more manageably endemic in areas, many clinical trials programs once entirely shuttered or retooled […]